Literature DB >> 29374878

[Chinese guideline for diagnosis and management of polycystic ovary syndrome].

.   

Abstract

Entities:  

Year:  2018        PMID： 29374878     DOI： 10.3760/cma.j.issn.0529-567X.2018.01.002

Source DB:  PubMed          Journal:  Zhonghua Fu Chan Ke Za Zhi        ISSN： 0529-567X


× No keyword cloud information.
  11 in total

1.  Decreased Sex Hormone-Binding Globulin Indicated Worse Biometric, Lipid, Liver, and Renal Function Parameters in Women with Polycystic Ovary Syndrome.

Authors:  Xi Luo; Xin-Ming Yang; Wang-Yu Cai; Hui Chang; Hong-Li Ma; Yan Peng; Xiao-Ke Wu
Journal:  Int J Endocrinol       Date:  2020-06-25       Impact factor: 3.257

2.  Characteristics of Pulse Parameters in Patients with Polycystic Ovary Syndrome Varied at Different Body Mass Index Levels.

Authors:  Xiao Feng; Lu Feng; Hui Gao; Qing-Sheng Wang; Yu-Mo Xia; Zhao-Xia Xu; Yi-Qin Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-02       Impact factor: 2.650

3.  Arachidonic Acid in Follicular Fluid of PCOS Induces Oxidative Stress in a Human Ovarian Granulosa Tumor Cell Line (KGN) and Upregulates GDF15 Expression as a Response.

Authors:  Yalan Ma; Lianwen Zheng; Yeling Wang; Yiyin Gao; Ying Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-11       Impact factor: 6.055

4.  Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.

Authors:  Tao Tao; Yi Zhang; Yu-Chen Zhu; Jia-Rong Fu; Yu-Ying Wang; Jie Cai; Jing-Yu Ma; Yu Xu; Yi-Ning Gao; Yun Sun; WuQiang Fan; Wei Liu
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

5.  Clinical Manifestations of Polycystic Ovary Syndrome and Associations With the Vaginal Microbiome: A Cross-Sectional Based Exploratory Study.

Authors:  Xiang Hong; Pengfei Qin; Jiechen Yin; Yong Shi; Yan Xuan; Zhengqi Chen; Xu Zhou; Hong Yu; Danhong Peng; Bei Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

6.  Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer.

Authors:  Liping Zong; Peihao Liu; Liguang Zhou; Daimin Wei; Lingling Ding; Yingying Qin
Journal:  Reprod Biol Endocrinol       Date:  2020-05-04       Impact factor: 5.211

7.  Letrozole Versus Clomiphene Citrate and Natural Cycle: Endometrial Receptivity During Implantation Window in Women With Polycystic Ovary Syndrome.

Authors:  Li Wang; Shulan Lv; Fen Li; E Bai; Xiaofeng Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-18       Impact factor: 5.555

8.  Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China.

Authors:  Ruilin Ma; Ying Zou; Wei Wang; Qingmei Zheng; Ying Feng; Han Dong; Zhangyun Tan; Xiaoqin Zeng; Yinqing Zhao; Yan Deng; Yanfang Wang; Aijun Sun
Journal:  BMC Endocr Disord       Date:  2021-09-06       Impact factor: 2.763

9.  Development and validation of a prediction model for depression in adolescents with polycystic ovary syndrome: A study protocol.

Authors:  Rui Ding; Heng Zhou; Xin Yan; Ying Liu; Yunmei Guo; Huiwen Tan; Xueting Wang; Yousha Wang; Lianhong Wang
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

10.  Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach.

Authors:  Yingyin Chen; Xinyi Chai; Ying Zhao; Xinqian Yang; Caiting Zhong; Yihui Feng
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-16       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.